OTCMKTS:SARTF Sartorius (SARTF) Stock Price, News & Analysis $261.99 0.00 (0.00%) As of 11/12/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and TrendsShort Interest About Sartorius Stock (OTCMKTS:SARTF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sartorius alerts:Sign Up Key Stats Today's Range$261.99▼$261.9950-Day Range$212.80▼$261.9952-Week Range$181.58▼$261.99VolumeN/AAverage Volume229 shsMarket Capitalization$8.97 billionP/E Ratio121.85Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sartorius is a life science company headquartered in Göttingen, Germany. Founded in 1870 as a precision-balance manufacturer, it has grown into a global supplier of technologies and services for biopharmaceutical production and laboratory research. The company’s bioprocessing products include filtration and fluid-management systems, single-use equipment, bioreactors, and technologies used in cell culture and purification. These solutions support the development and manufacture of biologic medicines, including vaccines and other advanced therapies. Sartorius also supplies laboratory instruments and consumables, such as balances, pipettes, and equipment for sample preparation and analysis. Its customers include pharmaceutical and biotechnology companies, research institutions, and laboratories worldwide.AI Generated. May Contain Errors. Read More Receive SARTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sartorius and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SARTF Stock News HeadlinesNachrichten Analysen Kurse Chart Xetra-Orderbuch DividendeOctober 22, 2026 | finanznachrichten.deSartorius Stedim Biotech Delivers Strong 2026 Growth and Confirms OutlookOctober 22, 2026 | tipranks.comTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.November 13 at 1:00 AM | Base Camp Trading (Ad)Sartorius Stedim Biotech Updates Share Capital and Voting RightsOctober 1, 2026 | tipranks.comSartorius Stedim Biotech Updates Share Capital and Voting Rights StructureSeptember 3, 2026 | tipranks.comSartorius Stedim Biotech Updates Market on Share Capital and Voting RightsAugust 4, 2026 | tipranks.comSartorius AG (SARTF) Q2 2026 Earnings Call Highlights: Strong Growth Amidst Market ChallengesJuly 23, 2026 | finance.yahoo.comSartorius Stedim Biotech Delivers H1 Growth and Confirms 2026 OutlookJuly 23, 2026 | tipranks.comSee More Headlines SARTF Stock Analysis - Frequently Asked Questions How have SARTF shares performed this year? Sartorius' stock was trading at $225.00 on January 1st, 2026. Since then, SARTF stock has increased by 16.4% and is now trading at $261.9850. How were Sartorius' earnings last quarter? Sartorius (OTCMKTS:SARTF) released its quarterly earnings results on Thursday, October, 16th. The company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.25 by $0.01. The business earned $987.65 million during the quarter, compared to analyst estimates of $972.82 million. Sartorius had a trailing twelve-month return on equity of 8.19% and a net margin of 3.82%. Does Sartorius have any subsidiaries? Sartorius subsidiaries include these companies: Novasep’s chromatography division, ALS Automated Lab Solutions GmbH, Xell AG, CellGenix Inc., WaterSep BioSeparations LLC, BIA Separations, Biological Industries, and others. How do I buy shares of Sartorius? Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:SARTF Previous SymbolNASDAQ:SARTF CIKN/A Webwww.sartorius.com Phone495513080Fax49-55-1308-3289Employees14,042Year Founded1870Profitability EPS (Trailing Twelve Months)$2.15 Trailing P/E Ratio121.85 Forward P/E RatioN/A P/E GrowthN/ANet Income$90.90 million Net Margins3.82% Pretax Margin8.16% Return on Equity8.19% Return on Assets3.15% Debt Debt-to-Equity Ratio0.89 Current Ratio0.95 Quick Ratio0.49 Sales & Book Value Annual Sales$3.66 billion Price / Sales2.45 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares34,230,000Free FloatN/AMarket Cap$8.97 billion OptionableNot Optionable Beta0.98 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:SARTF) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersTrump’s Invisible Dollar ResetPorter Stansberry believes President Trump could be about to trigger the biggest change to America's money in ...Porter & Company | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
